Anti-PD-1 antibody-attenuated il-2 immunoconjugate formulations
TW202629251APending Publication Date: 2026-07-16CEPHALON INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114136402
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-09-23
- Filing Date
- 2025-09-22
- Publication Date
- 2026-07-16
Abstract
Disclosed herein are stable pharmaceutical formulations comprising anti-human PD-1 (hPD-1) antibody-modified human interleukin-2 (hIL-2) immunoconjugates and uses thereof.
Need to check novelty before this filing date? Find Prior Art